NINDS invites small business applications to develop new technology for proteomics and glycomics. This announcement is made together with 4 other NIH components and is supported by 2 funding mechanisms: R43/R44 and R41/R42.
Proteomics continues to be a rapidly expanding field. Proteomics technologies and methods in the three broad, interacting domains of biology, analytical chemistry, and informatics are still largely inadequate to address the bulk of challenging biological problems. This announcement encourages small businesses to develop broadly applicable research tools that address the core technical challenges in proteomics and glycomics, including—but not restricted to—robotics, sample preparation and pre-fractionation, analytical separations, gel and array imaging, quantitation, mass spectrometry, intelligent automated data acquisition, and improved informatics technologies.
Potential applicants should contact Dr. Danilo Tagle, program director, Neurogenetics Cluster, NINDS, at 301-496-5745 or email@example.com. For more information visit http://grants.nih.gov/grants/guide/pa-files/PA-11-215.html or http://grants.nih.gov/grants/guide/pa-files/PA-11-214.html.